[UPDATED: 29 October 2021] 1. What’s going on? 2. How is the new guideline different to the old one? 3. Why is the new guideline being welcomed? 4. Why was the old guideline problematic? 5. How did NICE arrive at the new guideline? 6. Was NICE overly harsh in using […]
To fully understand the future, it is important to know the past. Next week, we finally get to see that long awaited new NICE treatment guideline for ME/CFS. As regular readers will know, all indications so far suggest the new guideline will be dramatically different from the old one. Graded […]
I was delighted to be part of this panel discussion on Gez Medinger‘s YouTube channel, RUN-DMC. As many readers will know, Gez is a London-based film producer and director who has been debilitated with severe Long COVID ever since contracting Covid early in the pandemic. His YouTube channel is now […]
The BMJ are reporting that four members of NICE’s guideline committee on ME/CFS have stood down. One is the medical advisor of the ME Association, who stated yesterday that he found it too difficult to combine membership of the committee with his wish to comment publicly in the media about […]
David Tuller (University of California, Berkeley), Steven Lubet (Northwestern University), and I have written an opinion piece over at Health Affairs. It’s on the implications of recent developments in ME and chronic fatigue syndrome for the treatment of Long COVID. We argue that the paradigm shift signalled by the UK’s […]
Swiss Re Group, “one of the world’s leading providers of reinsurance and insurance,” recently hosted a virtual Expert Forum on “secondary” impacts of COVID. As would be expected, the insurance industry is especially interested in the financial implications of this new disease. The programme covered many of the biophysical sequelae […]
